financetom
Business
financetom
/
Business
/
Tesla's California car registrations down 12% in 2024, report shows
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tesla's California car registrations down 12% in 2024, report shows
Feb 3, 2025 11:59 AM

Feb 3 (Reuters) - Tesla's electric-vehicle

registrations in California fell about 12% last year, according

to industry data, indicating mounting challenges for the

automaker in the key U.S. market.

While high interest rates, tough competition and the

introduction of a restyled Model 3 sedan hurt the EV maker's

sales in California, the loss of business was likely exacerbated

by CEO Elon Musk's involvement in the U.S. election.

"Things aren't looking so golden for Tesla in the Golden

State. Tesla's dominance in the electric-vehicle market

continues to falter as the brand reported its fifth consecutive

quarterly registration decline," California New Car Dealers

Association said in a report published on Jan. 31.

Still, the Model Y crossover continued to be the top-selling

vehicle in the state, with about 129,000 units sold last year.

The Model 3 sedan was a distant second, with around 53,000 cars

delivered.

Sales of the Model 3 fell about 36% from a year earlier,

according to data sourced by the industry body, which was first

reported by Bloomberg News earlier in the day.

Tesla's global deliveries fell for the first time last year,

pressured by high borrowing costs and competition from Chinese

and European automakers.

Reuters exclusively reported in November that Donald Trump's

transition team was planning to kill the $7,500 consumer tax

credit for EV purchases as part of broader tax-reform

legislation.

If the Trump administration scraps the federal tax credit

for EV purchases, California may introduce state tax credits

under a new proposal and Tesla's EV likely would not qualify for

the incentives, Governor Gavin Newsom's office had then said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Etihad in talks for Airbus jets ahead of Dubai Airshow, sources say
Etihad in talks for Airbus jets ahead of Dubai Airshow, sources say
Nov 13, 2025
PARIS, Nov 13 (Reuters) - Abu Dhabi's Etihad is in talks with Airbus to expand its fleet of long-haul jets with a potential order for more A350 aircraft as well as the upgraded A330neo, industry sources said. If a deal is finalised, the order could be announced as soon as next week's Dubai Airshow, the sources added. Etihad, which earlier...
Biotech Immunic's Q3 net loss widens
Biotech Immunic's Q3 net loss widens
Nov 13, 2025
Overview * Immunic ( IMUX ) reports Q3 net loss of $25.6 mln, with insufficient cash for 12 months * R&D expenses decreased by $1.4 mln in Q3 2025 compared to Q3 2024 Outlook * Company expects top-line data from phase 3 ENSURE trials by end of 2026 * Company preparing further clinical testing of IMU-856, contingent on financing Result...
Disney boosts dividend and buyback, parks and streaming drive profit beat
Disney boosts dividend and buyback, parks and streaming drive profit beat
Nov 13, 2025
LOS ANGELES (Reuters) -Walt Disney ( DIS ) said on Thursday it would boost its dividend by 50% and double its share buyback plan for fiscal 2026, as the media giant's streaming and parks businesses powered a quarterly earnings beat. Disney ( DIS ) posted an adjusted earnings per share of $1.11 for its fourth quarter ending in September, a...
Zura Bio Q3 net loss narrows despite higher R&D costs
Zura Bio Q3 net loss narrows despite higher R&D costs
Nov 13, 2025
Overview * Zura Bio ( ZURA ) Q3 net loss narrows to $20 mln, down from $22.9 mln last year * R&D expenses rise to $11.9 mln in Q3, reflecting tibulizumab trial advancement Outlook * Zura Bio expects topline data from tibulizumab trials in H2 2026 * Company anticipates cash to fund operations through 2027 * Zura Bio ( ZURA...
Copyright 2023-2026 - www.financetom.com All Rights Reserved